Newsroom
Securities Law Firms Investigate Insulet Corporation Class Action Lawsuit
By KlickAnalytics Data Insights | August 31, 2026 08:03PM ET
Key Points
- Faruqi & Faruqi, LLP reminds Insulet (PODD) investors of the securities class action lawsuit deadline on August 31, 2026.
- Rosen Law Firm urges Insulet Corporation investors to secure counsel before the important deadline.
- Bronstein, Gewirtz & Grossman LLC announces a class action lawsuit against Insulet Corporation.
- Levi & Korsinsky reminds Insulet Corporation investors of the pending class action lawsuit with a lead plaintiff deadline of August 31, 2026.
- Multiple law firms are offering investors the opportunity to lead securities fraud lawsuits against Insulet Corporation.
Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims against Insulet Corporation ("Insulet" or the "Company"). Investors who are interested in seeking the role of lead plaintiff in a federal securities class action that has been filed against the company must do so by the August 31, 2026 deadline. The law firm has offices in New York, Pennsylvania, California, and Georgia.
Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Insulet Corporation securities during the Class Period between February 21, 2025, and May 26, 2026, about the important lead plaintiff deadline on August 31, 2026. Investors who bought Insulet securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement.
Bronstein, Gewirtz & Grossman LLC have announced a class action lawsuit against Insulet Corporation and certain officers of the company. The lawsuit seeks to recover damages against the defendants for alleged violations of federal securities laws on behalf of individuals and entities that purchased or acquired Insulet securities between May 21, 2025, and May 26, 2026.
Levi & Korsinsky is reminding Insulet Corporation investors of the pending class action lawsuit with a lead plaintiff deadline of August 31, 2026. The company's SEC filings highlighted quality assurance inspections at various stages in the manufacturing cycle. However, issues at its Acton facility allegedly led to medical device corrections that impacted millions of pods.
Several law firms, including SBS Law, DJS Law Group, and Schall Brown & Schwartz LLP, are encouraging investors to lead securities fraud lawsuits against Insulet Corporation. These firms are reminding shareholders of a class action lawsuit against the company for violations of securities laws, including §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated by the U.S. Securities and Exchange Commission.
Overall, securities law firms are actively investigating potential claims against Insulet Corporation, urging investors to act before the lead plaintiff deadline, and offering opportunities for shareholders to lead securities fraud lawsuits against the company. Investors who purchased Insulet securities during specific timeframes should seek legal counsel to explore their rights and potential compensation options.
For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with